Previous 10 | Next 10 |
REDWOOD CITY, Calif. , Aug. 10, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported its second quart...
A Quick List Of Penny Stocks To Watch This Month Markets are looking to extend gains from last week and penny stocks are part of the mix. There were plenty of sectors heading toward new highs last week including technology and healthcare. However, coronavirus cases remain a sticking point fo...
REDWOOD CITY, Calif. , Aug. 3, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced that it will release second quarter financial results after market close on Monday, August 10, 2020 . AcelRx management will host a live we...
REDWOOD CITY, Calif. , July 23, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced an agreement to market DSUVIA®, a sublingual opioid tablet in a single-dose applicator, within the dental and oral surgery m...
REDWOOD CITY, Calif. , July 23, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced it has entered in...
Nikola (NASDAQ: NKLA ) -18% on share offer filing by company and shareholders. More news on: Nikola Corporation, Xtant Medical Holdings, Inc., One Stop Systems, Inc., Stocks on the move, , Read more ...
RumbleON (NASDAQ: RMBL ) +117% on pilot program with CarGurus. More news on: RumbleON, Inc., Verona Pharma plc, Applied DNA Sciences, Inc., Stocks on the move, , Read more ...
I first discussed AcelRx ( ACRX ) approximately one year ago in "AcelRx: The Pain Of The Launch". I was neutral on the stock at the time insofar as it was just starting its Dsuvia launch. This article reviews the twists and turns that AcelRx has encountered over the intervening year. As I ...
The bidding competition for Tetraphase Pharmaceuticals (NASDAQ: TTPH ) is not over yet. La Jolla Pharmaceutical (NASDAQ: LJPC ) has submitted an unsolicited bid of $43.0M in cash plus an additional $16.0 payable under contingent value rights (CVRs). More news on: Tetraphase Pharmaceutica...
The following healthcare companies have filed prospectuses for mixed shelf offerings: More news on: Genprex, Inc., Syros Pharmaceuticals, Inc., ChromaDex Corporation, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
AcelRx Pharmaceuticals Inc. Company Name:
ACRX Stock Symbol:
NASDAQ Market:
AcelRx Pharmaceuticals Inc. Website:
AcelRx Announces Rebranding With Name Change to Talphera, Inc. PR Newswire Name change to "Talphera" reflects a new era of the Company in partnership with the medical community developing novel solutions for medically supervised settings Talphera will begin trading on ...
AcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United States PR Newswire Use of CRRT increased during COVID and remained at these higher utilization levels Study results demonst...
AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update PR Newswire Niyad™ Investigational Device Exemption (IDE) approval by the FDA achieved in third quarter Company plans to begin its Niyad registrational study this quarter with topl...